US Broker Ratings

Valneva SE (VALN) Stock Analysis: Promising Upside with 54.69% Growth Potential

Valneva SE (VALN), a French biotechnology company specializing in the development and commercialization of prophylactic vaccines, is currently capturing investor attention with its potential for significant upside. The company, listed..

Bioventus Inc. (BVS) Stock Analysis: Unveiling a 75% Potential Upside in the Medical Device Sector

Bioventus Inc. (NASDAQ: BVS), a key player in the healthcare sector with a focus on medical devices, presents a compelling investment opportunity for those looking to tap into the innovative..

Personalis, Inc. (PSNL) Stock Analysis: A Look at Its 47.75% Potential Upside

For investors keen on exploring the diagnostic and research landscape within the healthcare sector, Personalis, Inc. (NASDAQ: PSNL) offers a compelling opportunity. With a market capitalization of $423.88 million, Personalis..

AxoGen, Inc. (AXGN) Stock Analysis: Exploring a High Potential Upside of 52.37%

AxoGen, Inc. (NASDAQ: AXGN) stands out in the healthcare sector, specifically within the medical devices industry, as a company that is pioneering the development and commercialization of technologies for peripheral..

Zenas BioPharma, Inc. (ZBIO) Stock Analysis: A Biotech Gem with a 94% Potential Upside

Zenas BioPharma, Inc. (NASDAQ: ZBIO) stands out in the biotechnology sector, not only for its innovative approach to immunology-based therapies but also for the significant upside potential it offers investors...

Replimune Group, Inc. (REPL) Stock Analysis: Navigating Biotech with a 9.72% Potential Downside

Replimune Group, Inc. (NASDAQ: REPL) stands out in the competitive biotechnology sector as a clinical-stage company focused on pioneering oncolytic immunotherapies to combat cancer. Based in Woburn, Massachusetts, Replimune is..

ArriVent BioPharma (AVBP) Investor Outlook: Analysts Predict a Potential 105.91% Upside

ArriVent BioPharma, Inc. (AVBP) is drawing significant attention in the biotechnology sector, primarily due to its promising pipeline and the optimistic outlook from analysts. With a market capitalization of $779.33..

CureVac N.V. (CVAC) Stock Analysis: Navigating the mRNA Frontier with Strategic Developments

CureVac N.V. (NASDAQ: CVAC) is a prominent player in the biotechnology industry, with a focus on developing transformative medicines based on messenger RNA (mRNA) technology. Headquartered in Tübingen, Germany, CureVac..

Enhabit, Inc. (EHAB) Stock Analysis: Exploring a Potential 18% Upside in the Healthcare Sector

Investors seeking opportunities in the healthcare sector might find Enhabit, Inc. (NASDAQ: EHAB) an intriguing prospect. With its focus on home health and hospice services, Enhabit serves a critical role..

MeiraGTx Holdings plc (MGTX): Unveiling a Potential 264.93% Upside in Biotechnology

Investors with an eye on the biotechnology sector should pay close attention to MeiraGTx Holdings plc (NASDAQ: MGTX), a clinical-stage gene therapy company that is creating ripples in the healthcare..

LifeMD, Inc. (LFMD) Stock Analysis: Exploring a 99% Upside Potential in Telehealth Innovation

LifeMD, Inc. (LFMD) is carving a niche in the burgeoning telehealth sector, presenting a compelling opportunity for investors focused on healthcare innovation. Operating in the health information services industry, LifeMD..

Nuvation Bio Inc. (NUVB) Stock Analysis: Exploring a Potential 156.85% Upside in the Biotech Sector

Nuvation Bio Inc. (NASDAQ: NUVB) is making waves in the biotechnology sector with its promising pipeline of oncology-focused therapeutic candidates. Despite its current stock price of $2.92, the company has..

AnaptysBio, Inc. (ANAB) Investor Outlook: Exploring a Potential 126% Upside

AnaptysBio, Inc. (NASDAQ: ANAB) is capturing investor attention with its impressive potential upside of 126.03%, according to recent analyst ratings. As a clinical-stage biotechnology firm, AnaptysBio is strategically positioned in..

HealthStream, Inc. (HSTM) Stock Analysis: Evaluating a 21.08% Potential Upside in Healthcare SaaS

HealthStream, Inc. (NASDAQ: HSTM), a prominent player in the healthcare information services sector, offers a unique investment opportunity with a potential upside of 21.08%. As a provider of Software-as-a-Service (SaaS)..

Kura Oncology, Inc. (KURA) Stock Analysis: Exploring 234% Potential Upside

Kura Oncology, Inc. (NASDAQ: KURA) has been capturing the attention of investors in the healthcare sector, particularly within the biotechnology industry. This San Diego-based clinical-stage biopharmaceutical company specializes in developing..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating a 39% Upside in a Challenging Market

Cross Country Healthcare, Inc. (NASDAQ: CCRN) is a prominent player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $438.03 million, the company..

Castle Biosciences, Inc. (CSTL) Investor Outlook: Unpacking a 51.85% Potential Upside

Castle Biosciences, Inc. (NASDAQ: CSTL), a prominent player in the healthcare sector, specifically in diagnostics and research, is generating buzz among investors with its robust potential upside of 51.85%. Based..

InnovAge Holding Corp. (INNV) Stock Analysis: Evaluating a 30.55% Potential Upside in the Healthcare Sector

InnovAge Holding Corp. (NASDAQ: INNV), a key player in the healthcare sector, specifically within the medical care facilities industry, is currently navigating a complex landscape. With its headquarters in Denver,..

Zevra Therapeutics, Inc. (ZVRA)

⚠️ No article content returned.

..

AMN Healthcare Services Inc (AMN) Stock Analysis: Navigating a Challenging Healthcare Staffing Market

AMN Healthcare Services Inc (AMN), a notable player in the healthcare sector, is grappling with a challenging landscape within the medical care facilities industry. With a market capitalization of $768.4..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds